Global Prostate Cancer Diagnostics Market Insights, Forecast to 2025

1 Study Coverage

• 1.1 Prostate Cancer Diagnostics Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Prostate Cancer Diagnostics Market Size Growth Rate by Type
  • 1.2.2 Tumor Biomarker Tests
  • 1.2.3 Imaging
  • 1.2.4 Biopsy
  • 1.2.5 Other
• 1.3 Market by Application
  • 1.3.1 Global Prostate Cancer Diagnostics Market Size Growth Rate by Application
  • 1.3.2 age < 55
  • 1.3.3 age 55-75
  • 1.3.4 age > 75
• 1.4 Study Objectives
• 1.5 Years Considered

2 Executive Summary

• 2.1 Global Prostate Cancer Diagnostics Market Size Estimates and Forecasts
  • 2.1.1 Global Prostate Cancer Diagnostics Revenue 2015-2026
  • 2.1.2 Global Prostate Cancer Diagnostics Sales 2015-2026
• 2.2 Prostate Cancer Diagnostics Market Size by Region: 2020 Versus 2026
• 2.3 Prostate Cancer Diagnostics Sales by Region (2015-2026)
  • 2.3.1 Global Prostate Cancer Diagnostics Sales by Region: 2015-2020
  • 2.3.2 Global Prostate Cancer Diagnostics Sales Forecast by Region (2021-2026)
  • 2.3.3 Global Prostate Cancer Diagnostics Sales Market Share by Region (2015-2026)
• 2.4 Prostate Cancer Diagnostics Market Estimates and Projections by Region (2021-2026)
  • 2.4.1 Global Prostate Cancer Diagnostics Revenue by Region: 2015-2020
  • 2.4.2 Global Prostate Cancer Diagnostics Revenue Forecast by Region (2021-2026)
  • 2.4.3 Global Prostate Cancer Diagnostics Revenue Market Share by Region (2015-2026)

3 Global Prostate Cancer Diagnostics by Manufacturers

• 3.1 Global Top Prostate Cancer Diagnostics Manufacturers by Sales
  • 3.1.1 Global Prostate Cancer Diagnostics Sales by Manufacturer (2015-2020)
  • 3.1.2 Global Prostate Cancer Diagnostics Sales Market Share by Manufacturer (2015-2019)
• 3.2 Global Top Prostate Cancer Diagnostics Manufacturers by Revenue
  • 3.2.1 Global Prostate Cancer Diagnostics Revenue by Manufacturer (2015-2020)
  • 3.2.2 Global Prostate Cancer Diagnostics Revenue Share by Manufacturer (2015-2020)
• 3.3 Global Prostate Cancer Diagnostics Price by Manufacturer (2015-2020)
• 3.4 Competitive Landscape
  • 3.4.1 Key Prostate Cancer Diagnostics Manufacturers Covered: Ranking by Revenue
  • 3.4.2 Global Prostate Cancer Diagnostics Market Concentration Ratio (CR5 and HHI) & (2015-2020)
  • 3.4.3 Global Prostate Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.5 Global Prostate Cancer Diagnostics Manufacturing Base Distribution, Product Type
  • 3.5.1 Prostate Cancer Diagnostics Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.5.2 Manufacturers Prostate Cancer Diagnostics Product Type
  • 3.5.3 Date of International Manufacturers Enter into Prostate Cancer Diagnostics Market
• 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Company Profiles

• 4.1 Genomic Health
  • 4.1.1 Genomic Health Corporation Information
  • 4.1.2 Genomic Health Description, Business Overview
  • 4.1.3 Genomic Health Prostate Cancer Diagnostics Products Offered
  • 4.1.4 Genomic Health Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
  • 4.1.5 Genomic Health Prostate Cancer Diagnostics Revenue by Product
  • 4.1.6 Genomic Health Prostate Cancer Diagnostics Revenue by Application
  • 4.1.7 Genomic Health Prostate Cancer Diagnostics Revenue by Geographic Area
  • 4.1.8 Genomic Health Prostate Cancer Diagnostics Revenue by Sales Channel
  • 4.1.9 Genomic Health Recent Development
• 4.2 Abbott
  • 4.2.1 Abbott Corporation Information
  • 4.2.2 Abbott Description, Business Overview
  • 4.2.3 Abbott Prostate Cancer Diagnostics Products Offered
  • 4.2.4 Abbott Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
  • 4.2.5 Abbott Prostate Cancer Diagnostics Revenue by Product
  • 4.2.6 Abbott Prostate Cancer Diagnostics Revenue by Application
  • 4.2.7 Abbott Prostate Cancer Diagnostics Revenue by Geographic Area
  • 4.2.8 Abbott Prostate Cancer Diagnostics Revenue by Sales Channel
  • 4.2.9 Abbott Recent Development
• 4.3 OPKO
  • 4.3.1 OPKO Corporation Information
  • 4.3.2 OPKO Description, Business Overview
  • 4.3.3 OPKO Prostate Cancer Diagnostics Products Offered
  • 4.3.4 OPKO Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
  • 4.3.5 OPKO Prostate Cancer Diagnostics Revenue by Product
  • 4.3.6 OPKO Prostate Cancer Diagnostics Revenue by Application
  • 4.3.7 OPKO Prostate Cancer Diagnostics Revenue by Geographic Area
  • 4.3.8 OPKO Prostate Cancer Diagnostics Revenue by Sales Channel
  • 4.3.9 OPKO Recent Development
• 4.4 Siemens Healthcare
  • 4.4.1 Siemens Healthcare Corporation Information
  • 4.4.2 Siemens Healthcare Description, Business Overview
  • 4.4.3 Siemens Healthcare Prostate Cancer Diagnostics Products Offered
  • 4.4.4 Siemens Healthcare Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
  • 4.4.5 Siemens Healthcare Prostate Cancer Diagnostics Revenue by Product
  • 4.4.6 Siemens Healthcare Prostate Cancer Diagnostics Revenue by Application
  • 4.4.7 Siemens Healthcare Prostate Cancer Diagnostics Revenue by Geographic Area
  • 4.4.8 Siemens Healthcare Prostate Cancer Diagnostics Revenue by Sales Channel
  • 4.4.9 Siemens Healthcare Recent Development
• 4.5 DiaSorin
  • 4.5.1 DiaSorin Corporation Information
  • 4.5.2 DiaSorin Description, Business Overview
  • 4.5.3 DiaSorin Prostate Cancer Diagnostics Products Offered
  • 4.5.4 DiaSorin Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
  • 4.5.5 DiaSorin Prostate Cancer Diagnostics Revenue by Product
  • 4.5.6 DiaSorin Prostate Cancer Diagnostics Revenue by Application
  • 4.5.7 DiaSorin Prostate Cancer Diagnostics Revenue by Geographic Area
  • 4.5.8 DiaSorin Prostate Cancer Diagnostics Revenue by Sales Channel
  • 4.5.9 DiaSorin Recent Development
• 4.6 BioMeriux
  • 4.6.1 BioMeriux Corporation Information
  • 4.6.2 BioMeriux Description, Business Overview
  • 4.6.3 BioMeriux Prostate Cancer Diagnostics Products Offered
  • 4.6.4 BioMeriux Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
  • 4.6.5 BioMeriux Prostate Cancer Diagnostics Revenue by Product
  • 4.6.6 BioMeriux Prostate Cancer Diagnostics Revenue by Application
  • 4.6.7 BioMeriux Prostate Cancer Diagnostics Revenue by Geographic Area
  • 4.6.8 BioMeriux Recent Development
• 4.7 Roche
  • 4.7.1 Roche Corporation Information
  • 4.7.2 Roche Description, Business Overview
  • 4.7.3 Roche Prostate Cancer Diagnostics Products Offered
  • 4.7.4 Roche Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
  • 4.7.5 Roche Prostate Cancer Diagnostics Revenue by Product
  • 4.7.6 Roche Prostate Cancer Diagnostics Revenue by Application
  • 4.7.7 Roche Prostate Cancer Diagnostics Revenue by Geographic Area
  • 4.7.8 Roche Recent Development
• 4.8 MDx Health
  • 4.8.1 MDx Health Corporation Information
  • 4.8.2 MDx Health Description, Business Overview
  • 4.8.3 MDx Health Prostate Cancer Diagnostics Products Offered
  • 4.8.4 MDx Health Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
  • 4.8.5 MDx Health Prostate Cancer Diagnostics Revenue by Product
  • 4.8.6 MDx Health Prostate Cancer Diagnostics Revenue by Application
  • 4.8.7 MDx Health Prostate Cancer Diagnostics Revenue by Geographic Area
  • 4.8.8 MDx Health Recent Development
• 4.9 Beckman Coulter
  • 4.9.1 Beckman Coulter Corporation Information
  • 4.9.2 Beckman Coulter Description, Business Overview
  • 4.9.3 Beckman Coulter Prostate Cancer Diagnostics Products Offered
  • 4.9.4 Beckman Coulter Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
  • 4.9.5 Beckman Coulter Prostate Cancer Diagnostics Revenue by Product
  • 4.9.6 Beckman Coulter Prostate Cancer Diagnostics Revenue by Application
  • 4.9.7 Beckman Coulter Prostate Cancer Diagnostics Revenue by Geographic Area
  • 4.9.8 Beckman Coulter Recent Development
• 4.10 Myriad Genetics
  • 4.10.1 Myriad Genetics Corporation Information
  • 4.10.2 Myriad Genetics Description, Business Overview
  • 4.10.3 Myriad Genetics Prostate Cancer Diagnostics Products Offered
  • 4.10.4 Myriad Genetics Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
  • 4.10.5 Myriad Genetics Prostate Cancer Diagnostics Revenue by Product
  • 4.10.6 Myriad Genetics Prostate Cancer Diagnostics Revenue by Application
  • 4.10.7 Myriad Genetics Prostate Cancer Diagnostics Revenue by Geographic Area
  • 4.10.8 Myriad Genetics Recent Development
• 4.11 Ambry Genetics
  • 4.11.1 Ambry Genetics Corporation Information
  • 4.11.2 Ambry Genetics Description, Business Overview
  • 4.11.3 Ambry Genetics Prostate Cancer Diagnostics Products Offered
  • 4.11.4 Ambry Genetics Prostate Cancer Diagnostics Sales, Revenue and Gross Margin (2015-2020)
  • 4.11.5 Ambry Genetics Prostate Cancer Diagnostics Revenue by Product
  • 4.11.6 Ambry Genetics Prostate Cancer Diagnostics Revenue by Application
  • 4.11.7 Ambry Genetics Prostate Cancer Diagnostics Revenue by Geographic Area
  • 4.11.8 Ambry Genetics Recent Development

5 Breakdown Data by Type

• 5.1 Global Prostate Cancer Diagnostics Sales by Type (2015-2026)
  • 5.1.1 Global Prostate Cancer Diagnostics Sales by Type (2015-2020)
  • 5.1.2 Global Prostate Cancer Diagnostics Sales Forecast by Type (2021-2026)
  • 5.1.3 Global Prostate Cancer Diagnostics Sales Market Share by Type (2015-2026)
• 5.2 Global Prostate Cancer Diagnostics Revenue Forecast by Type (2015-2026)
  • 5.2.1 Global Prostate Cancer Diagnostics Revenue by Type (2015-2020)
  • 5.2.2 Global Prostate Cancer Diagnostics Revenue Forecast by Type (2021-2026)
  • 5.2.3 Global Prostate Cancer Diagnostics Revenue Market Share by Type (2015-2026)
• 5.3 Prostate Cancer Diagnostics Average Selling Price (ASP) by Type (2015-2026)

6 Breakdown Data by Application

• 6.1 Global Prostate Cancer Diagnostics Sales by Application (2015-2026)
  • 6.1.1 Global Prostate Cancer Diagnostics Sales by Application (2015-2020)
  • 6.1.2 Global Prostate Cancer Diagnostics Sales Forecast by Application (2021-2026)
  • 6.1.3 Global Prostate Cancer Diagnostics Sales Market Share by Application (2015-2026)
• 6.2 Global Prostate Cancer Diagnostics Revenue Forecast by Application (2015-2026)
  • 6.2.1 Global Prostate Cancer Diagnostics Revenue by Application (2015-2020)
  • 6.2.2 Global Prostate Cancer Diagnostics Revenue Forecast by Application (2021-2026)
  • 6.2.3 Global Prostate Cancer Diagnostics Revenue Market Share by Application (2015-2026)
• 6.3 Prostate Cancer Diagnostics Average Selling Price (ASP) by Application (2015-2026)

7 North America

• 7.1 North America Prostate Cancer Diagnostics Market Size YoY Growth 2015-2026
• 7.2 North America Prostate Cancer Diagnostics Market Facts & Figures by Country
  • 7.2.1 North America Prostate Cancer Diagnostics Sales by Country (2015-2026)
  • 7.2.2 North America Prostate Cancer Diagnostics Revenue by Country (2015-2026)
• 7.3 North America Prostate Cancer Diagnostics Sales by Type
• 7.4 North America Prostate Cancer Diagnostics Sales by Application

8 Asia-Pacific

• 8.1 Asia-Pacific Prostate Cancer Diagnostics Market Size YoY Growth 2015-2026
• 8.2 Asia-Pacific Prostate Cancer Diagnostics Market Facts & Figures by Region
  • 8.2.1 Asia-Pacific Prostate Cancer Diagnostics Sales by Region (2015-2026)
  • 8.2.2 Asia-Pacific Prostate Cancer Diagnostics Revenue by Region (2015-2026)
• 8.3 Asia-Pacific Prostate Cancer Diagnostics Sales by Type
• 8.4 Asia-Pacific Prostate Cancer Diagnostics Sales by Application

9 Europe

• 9.1 Europe Prostate Cancer Diagnostics Market Size YoY Growth 2015-2026
• 9.2 Europe Prostate Cancer Diagnostics Market Facts & Figures by Country
  • 9.2.1 Europe Prostate Cancer Diagnostics Sales by Country (2015-2026)
  • 9.2.2 Europe Prostate Cancer Diagnostics Revenue by Country (2015-2026)
• 9.3 Europe Prostate Cancer Diagnostics Sales by Type
• 9.4 Europe Prostate Cancer Diagnostics Sales by Application

10 Latin America

• 10.1 Latin America Prostate Cancer Diagnostics Market Size YoY Growth 2015-2026
• 10.2 Latin America Prostate Cancer Diagnostics Market Facts & Figures by Country
  • 10.2.1 Latin America Prostate Cancer Diagnostics Sales by Country (2015-2026)
  • 10.2.2 Latin America Prostate Cancer Diagnostics Revenue by Country (2015-2026)
• 10.3 Latin America Prostate Cancer Diagnostics Sales by Type
• 10.4 Latin America Prostate Cancer Diagnostics Sales by Application

11 Middle East and Africa

• 11.1 Middle East and Africa Prostate Cancer Diagnostics Market Size YoY Growth 2015-2026
• 11.2 Middle East and Africa Prostate Cancer Diagnostics Market Facts & Figures by Country
  • 11.2.1 Middle East and Africa Prostate Cancer Diagnostics Sales by Country (2015-2026)
  • 11.2.2 Middle East and Africa Prostate Cancer Diagnostics Revenue by Country (2015-2026)
• 11.3 Middle East and Africa Prostate Cancer Diagnostics Sales by Type
• 11.4 Middle East and Africa Prostate Cancer Diagnostics Sales by Application

12 Supply Chain and Sales Channel Analysis

• 12.1 Prostate Cancer Diagnostics Supply Chain Analysis
• 12.2 Prostate Cancer Diagnostics Key Raw Materials and Upstream Suppliers
• 12.3 Prostate Cancer Diagnostics Clients Analysis
• 12.4 Prostate Cancer Diagnostics Sales Channel and Sales Model Analysis
  • 12.4.1 Prostate Cancer Diagnostics Distribution Channel Analysis: Indirect Sales VS Direct Sales
  • 12.4.2 Prostate Cancer Diagnostics Distribution Channel Analysis: Online Sales VS Offline Sales
  • 12.4.3 Prostate Cancer Diagnostics Distributors

13 Market Dynamics

• 13.1 Prostate Cancer Diagnostics Market Drivers
• 13.2 Prostate Cancer Diagnostics Market Opportunities
• 13.3 Prostate Cancer Diagnostics Market Challenges
• 13.4 Prostate Cancer Diagnostics Market Restraints
• 13.5 Porter’s Five Forces Analysis

14 Research Findings and Conclusion

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
  • 15.1.2 Data Source
• 15.2 Author Details